ALDO 03- International Symposium on Aldosterone (ALDO 03)
Venue: The Royal Society
|Event Date/Time: Jan 03, 2002|
In the 21st Century, research in aldosterone is undergoing a remarkable renaissance. There is increased clinical recognition of inappropriate aldosterone production in a higher proportion of essential hypertensives than was previously recognised. Recent clinical trials have demonstrated an important critical role for aldosterone in cardiovascular disease, especially heart failure, not only attributable to its secretion by the adrenal cortex, but also to its synthesis as a paracrine agent by the heart and the vasculature itself. Additionally, the discovery that some of its actions are mediated by non-genomic means, through the actions of membrane located receptors, offers huge opportunities both for research and for novel therapies
The meeting will be held on 28-30 April 2003, at the Royal Society, London UK.